12:00 AM
May 24, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Rituxan rituximab: Marketed

Data from 10 of the 18 patients enrolled in an ongoing 40-patient pilot study showed that the combination of Rituxan and fludarabine chemotherapy gave 6 complete remissions, 1 partial remission,...

Read the full 130 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >